Double Blind Trial with Prenylamine (Segontin) in Coronary Insufficiency
1966; Wiley; Volume: 180; Issue: 2 Linguagem: Inglês
10.1111/j.0954-6820.1966.tb02817.x
ISSN0001-6101
AutoresK. A. Jacobsson, Günter Koch, MAJ LEVANDER‐LINDGREN, Gunnar Michaelsson,
Tópico(s)Fungal Plant Pathogen Control
ResumoActa Medica ScandinavicaVolume 180, Issue 2 p. 129-138 Double Blind Trial with Prenylamine (Segontin) in Coronary Insufficiency K. A. Jacobsson, K. A. Jacobsson Department of Internal Medicine (Head: N. Törnblom) and the Department of Clinical Physiology (Head: H. Linderholm), University of Umeå, Umeå, SwedenSearch for more papers by this authorGünter Koch, Günter Koch Department of Internal Medicine (Head: N. Törnblom) and the Department of Clinical Physiology (Head: H. Linderholm), University of Umeå, Umeå, SwedenSearch for more papers by this authorMaj Levander-Lindgren, Maj Levander-Lindgren Department of Internal Medicine (Head: N. Törnblom) and the Department of Clinical Physiology (Head: H. Linderholm), University of Umeå, Umeå, SwedenSearch for more papers by this authorGunnar Michaelsson, Gunnar Michaelsson Department of Internal Medicine (Head: N. Törnblom) and the Department of Clinical Physiology (Head: H. Linderholm), University of Umeå, Umeå, SwedenSearch for more papers by this author K. A. Jacobsson, K. A. Jacobsson Department of Internal Medicine (Head: N. Törnblom) and the Department of Clinical Physiology (Head: H. Linderholm), University of Umeå, Umeå, SwedenSearch for more papers by this authorGünter Koch, Günter Koch Department of Internal Medicine (Head: N. Törnblom) and the Department of Clinical Physiology (Head: H. Linderholm), University of Umeå, Umeå, SwedenSearch for more papers by this authorMaj Levander-Lindgren, Maj Levander-Lindgren Department of Internal Medicine (Head: N. Törnblom) and the Department of Clinical Physiology (Head: H. Linderholm), University of Umeå, Umeå, SwedenSearch for more papers by this authorGunnar Michaelsson, Gunnar Michaelsson Department of Internal Medicine (Head: N. Törnblom) and the Department of Clinical Physiology (Head: H. Linderholm), University of Umeå, Umeå, SwedenSearch for more papers by this author First published: January/December 1966 https://doi.org/10.1111/j.0954-6820.1966.tb02817.xCitations: 7AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Abrahamsen, A. M.: Cardiac catheterization studies following injection of Synadrin. Acta med. scand. 174: 265, 1963. 10.1111/j.0954-6820.1963.tb07922.x CASPubMedWeb of Science®Google Scholar 2 Anderson, D. E.: Prenylamine (Segontin) in angina of effort. Med. J. Aust. 50: 149, 1963. PubMedGoogle Scholar 3 Baumgarten, A.: The clinical effects of a new anti-anginal agent, Prenylamine (Segontin). Med. J. Aust. 49: 429, 1962. PubMedGoogle Scholar 4 Borg, G. A. V.: Physical performance and perceived exertion. Gleerup, Lund 1962. Google Scholar 5 Brandschwede, S.: Elektrokardiographische Untersuchungen bei der Behandlung der Koronarinsuffizienz mit Segontin. Med. Welt (Bert.) 35: 1781, 1960. Google Scholar 6 Burman, I.: Kreislaufbeobachtungen bei der Behandlung der Koronar-Insuffizienz. Med. Welt (Bert.) 4: 188, 1961. Google Scholar 7 Böhm, C, Schlepper, M. & Witzleb, E.: Eine neue Koronargefässerweiternde Substanz. Experimentelle und Klinische Untersuchungen. Dtsch. med. Wschr. 85: 1405, 1960. 10.1055/s-0028-1112595 Web of Science®Google Scholar 8 Dahl, M., Kusanen, A. & Peltonen, T.: The effect of Segontin, Persantin and Nitroglycerine on the coronary artery (experimental studies with cinecoronarography). Ann. Med. exp. Fenn. 40: 423, 1962. CASPubMedWeb of Science®Google Scholar 9 Davis, N. J.: Prenylamine (Segontin) in angina of effort. Med. J. Aust. 50: 487, 1963. Google Scholar 10 Della Porta, P. & Lucchini, C. R.: Primi osservazioni cliniche nell' uso di una nuova sintesi (N-(3′-fenil-propil-(2′)-)-1,1-difenil-propil-(3) amina, (Segontin)) nelle sindromi di insufficienza coronarica. Minerva Cardioangiol. 9: 533, 1961. CASPubMedGoogle Scholar 11 Gerstner, K.: Zur Behandlung des Angina-pectoris-Symptomenkomplexes mit Segontin. Wien. med. Wschr. 111: 529, 1961. CASPubMedWeb of Science®Google Scholar 12 Helbig, J.: Elektrokardiographische Untersuchungen und klinische Beobachtungen über die Wirkung von Segontin beim Angina-pectoris-Syndrom. Münch. med. Wschr. 103: 100, 1961. CASPubMedWeb of Science®Google Scholar 13 Holmgren, A. & Mattson, K. H.: A new ergometer with constant work load at varying pedalling rate. Scand. J. clin. Lab. Invest. 6: 137, 1954. 10.3109/00365515409134855 CASPubMedWeb of Science®Google Scholar 14 Holmgren, A. & Strandell, T.: On the use of chest head leads for recording of electrocardiogram during exercise. Acta med. scand. 169: 57, 1961. 10.1111/j.0954-6820.1961.tb17093.x CASPubMedWeb of Science®Google Scholar 15 Kerridge, D. F., Mazurkie, S. J. & Verel, D.: A clinical trial of prenylamine lactate — a long lasting coronary dilatator drug. Canad. med. Ass. J. 85: 1352, 1961. CASPubMedWeb of Science®Google Scholar 16 Kochsiek, K., Bretschneider, H. J. & Scheler, E.: Vergleichende experimentelle Untersuchungen über die coronargefässerweiternde Wirkung von Phenyl-propyl-diphenyl-propyl-amin. Arzneimittel-Forsch. 10: 576, 1960. CASPubMedWeb of Science®Google Scholar 17 Lauenroth, G.: Über neue Möglichkeiten in der Behandlung der coronaren Durchblutungsstörungen. Med. Klin. 55: 1434, 1960. CASPubMedGoogle Scholar 18 Likoff, W., Kasparian, H., Lehman, J. S. & Segal, B. L.: Evaluation of "coronary vasodilatators" by coronary arteriography. Amer. J. Cardiol. 13: 7, 1964. 10.1016/0002-9149(64)90215-2 CASPubMedWeb of Science®Google Scholar 19 Lindner, E.: Phenyl-propyl-diphenyl-propyl-amin, eine neue Substanz mit coronargefässerweiternder Wirkung. Arzneimittel-Forsch. 10: 569, 1960. CASPubMedWeb of Science®Google Scholar 20 Maltez, J. S.: Resultados do tratamento da insuficiência coronária pelo N-(3′-fenil-propil- (2′))-1,1 -difenil-propil-(3)-amina (Segontin). J. Med. (Pôrto) 50: 189, 1963. CASPubMedGoogle Scholar 21 Michel, D.: Hämodynamische Effekte nach Segontin-Injection. Med. Klin. 55: 1428, 1960. Google Scholar 22 Neumann, M. & Luisada, A. A.: Effect of rapid and slow-acting "coronary" drugs on precordial pain of the aged. Amer. J. med. Sci. 247: 156, 1964. 10.1097/00000441-196402000-00004 CASPubMedWeb of Science®Google Scholar 23 Overkamp, H.: Doppelblindversuche mit dem Coronartherapeuticum Segontin. Med. Klin. 55: 1423, 1960. CASPubMedGoogle Scholar 24 Ratschow, M. & Schoop, W.: Ergebnisse von 20 Kliniken mit der Segontin-Behandlung der Angina pectoris. Med. Klin. 55: 1436, 1960. CASPubMedGoogle Scholar 25 Sahm, F.: Zur Behandlung der als Nebenbefund ermittelten Coronarinsuffizienz. Med Klin. 55: 1426, 1960. CASPubMedGoogle Scholar 26 Sandberg, L.: Studies on electrographic changes during exercise tests. Acta med. scand. Suppl. 365, 1961. Google Scholar 27 Schöne, H. H. & Lindner, E.: Die Wirkung des N-(3′-Phenyl-propyl-(2′)-1,1-diphenyl-propyl-(3)-amins) auf den Stoffwechsel von Serotonin und Noradrenalin. Arzneimittel-Forsch. 10: 583, 1960. CASWeb of Science®Google Scholar 28 Schöne, H. H. & Lindner, E.: Über die Wirkung von N-(3′-Phenyl-propyl-(2′)-1,1-diphenyl-propyl-(3)-amin auf den Katecholamin-Stoffwechsel. Klin. Wschr. 40: 1196, 1962. 10.1007/BF01494326 Web of Science®Google Scholar 29 Sjöstrand, T.: The electrocardiographic work and hypoxemia tests. Scand. J. clin. Lab. Invest. 3: 1, 1951. 10.3109/00365515109060563 CASPubMedWeb of Science®Google Scholar 30 Sjöstrand, T.: Functional capacity and exercise tolerance in patients with impaired cardiovascular function. Clinical cardiopulmonary physiology. Grune & Stratton Inc., New York 1960. Google Scholar 31 Sosa, J. A. & McGregor, M.: Prenylamine in angina pectoris. Canad. med. Ass. J. 89: 248, 1963. CASPubMedWeb of Science®Google Scholar 32 Strandell, T.: Electrographic findings at rest, during and after exercise in healthy old men compared with young men. Acta med. scand. 174: 479, 1963. 10.1111/j.0954-6820.1963.tb07948.x CASPubMedWeb of Science®Google Scholar 33 Thieme, H. J.: Zur Klinik des Herzinfarktes. Ther. d. Gegenw. 100: 507, 1961. CASPubMedGoogle Scholar 34 Wahlund, H.: Determination of the physical working capacity. Acta med. scand. Suppl. 215, 1948. Google Scholar Citing Literature Volume180, Issue2January/December 1966Pages 129-138 ReferencesRelatedInformation
Referência(s)